116 related articles for article (PubMed ID: 11195848)
21. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
Segreti J; Kessler HA; Kapell K; Trenholme GM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):87S-88S. PubMed ID: 2791503
[TBL] [Abstract][Full Text] [Related]
22. Susceptibility pattern of bacterial isolates to lomefloxacin.
Lalitha MK; Nisha AK; Bhattacharya SS; Ramamoorthy U; Lal HM
Indian J Med Res; 1990 May; 91():182-4. PubMed ID: 2397938
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.
DiVincenzo CA; Shatzer KL; Venezio FR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):13S-16S. PubMed ID: 2507220
[TBL] [Abstract][Full Text] [Related]
24. Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.
Zhao B; Chignell CF; Rammal M; Smith F; Hamilton MG; Andley UP; Roberts JE
Photochem Photobiol; 2010; 86(4):798-805. PubMed ID: 20528972
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of CP-74667 compared with four other fluoroquinolones.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
[TBL] [Abstract][Full Text] [Related]
26. Studies on the emergence of resistance to lomefloxacin in vitro.
Kanematsu M; Greenwood D
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):741-5. PubMed ID: 2506046
[TBL] [Abstract][Full Text] [Related]
27. Different mechanisms for the photoinduced production of oxidative DNA damage by fluoroquinolones differing in photostability.
Spratt TE; Schultz SS; Levy DE; Chen D; Schlüter G; Williams GM
Chem Res Toxicol; 1999 Sep; 12(9):809-15. PubMed ID: 10490502
[TBL] [Abstract][Full Text] [Related]
28. Induced and photoinduced DNA damage by quinolones: ciprofloxacin, ofloxacin and nalidixic acid determined by comet assay.
Sánchez G; Hidalgo ME; Vivanco JM; Escobar J
Photochem Photobiol; 2005; 81(4):819-22. PubMed ID: 15691228
[TBL] [Abstract][Full Text] [Related]
29. In vitro phototoxicity of new quinolones: production of active oxygen species and photosensitized lipid peroxidation.
Kawada A; Hatanaka K; Gomi H; Matsuo I
Photodermatol Photoimmunol Photomed; 1999 Dec; 15(6):226-30. PubMed ID: 10599972
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
[TBL] [Abstract][Full Text] [Related]
31. Impairment of phagocytic cell respiratory burst by UVA in the presence of fluoroquinolones: an oxygen-dependent phototoxic damage to cell surface microvilli.
Saniabadi AR; Wada K; Umemura K; Sakuma S; Nakashima M
J Photochem Photobiol B; 1996 Apr; 33(2):137-42. PubMed ID: 8691354
[TBL] [Abstract][Full Text] [Related]
32. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
33. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer.
Rolston KV; Ho DH; LeBlanc B; Streeter H; Dvorak T
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():15-22. PubMed ID: 9222065
[TBL] [Abstract][Full Text] [Related]
34. In vitro phototoxic activities of new quinolone antibacterial agents: lipid peroxidative potentials.
Fujita H; Matsuo I
Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):202-5. PubMed ID: 7880759
[TBL] [Abstract][Full Text] [Related]
35. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
[TBL] [Abstract][Full Text] [Related]
36. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
Molinari G; Bandelloni R; Paglia P; Debbia E; Schito GC
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):53S-56S. PubMed ID: 2791499
[TBL] [Abstract][Full Text] [Related]
37. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
Allemandi DA; Alovero FL; Manzo RH
J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
[TBL] [Abstract][Full Text] [Related]
38. [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
Yamane N; Chilima BZ; Tosaka M; Okazawa Y; Tanno K
Kekkaku; 1996 Aug; 71(8):453-8. PubMed ID: 8831190
[TBL] [Abstract][Full Text] [Related]
39. Compare two methods of measuring DNA damage induced by photogenotoxicity of fluoroquinolones.
Zhang T; Li JL; Xin J; Ma XC; Tu ZH
Acta Pharmacol Sin; 2004 Feb; 25(2):171-5. PubMed ID: 14769204
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
Piersimoni C; Morbiducci V; Bornigia S; De Sio G; Scalise G
Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
